Latest Period
Q4 2025
Security Snapshot
Sensei Biotherapeutics, Inc. - Common Shares, no par value per share (SNSE) Institutional Ownership
CUSIP: 81728A207
13F Institutional Holders and Ownership History from Q1 2025 to Q4 2025
Institutions Reporting
10
Shares (Excl. Options)
48,247
Price
$10.67
- Type / Class
- Equity / Common Shares, no par value per share
- Symbol
- SNSE on Nasdaq
- Shares outstanding
- 1,272,828
- Price per share
- $31.20
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 48,247
- Total reported value
- $514,780
- % of total 13F portfolios
- 0%
- Share change
- -1,088
- Value change
- -$10,572
- Number of holders
- 10
- Price from insider filings
- $31.20
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- SNSE - Sensei Biotherapeutics, Inc. - Common Shares, no par value per share is tracked under CUSIP 81728A207.
- 10 institutions reported positions in Q4 2025.
- 1 significant owner is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 9 to 10 between Q3 2025 and Q4 2025.
- Reported value moved from $466,215 to $514,780.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Official SEC Source
Backed by Form 13F
Ownership context comes from SEC Form 13F and, when available, Schedule 13D/13G filings.
See Original FilingInvestment Quick Answers
What is CUSIP 81728A207?
CUSIP 81728A207 identifies SNSE - Sensei Biotherapeutics, Inc. - Common Shares, no par value per share in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Continue Investment Research
- Latest 13F filings for new institutional portfolio disclosures.
- Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
- Latest 10-Q/10-K reports to cross-check issuer fundamentals.
- Recent insider transactions for management buying/selling context.
- SEC investors directory and top value investors for manager-level discovery.
- All institutional ownership pages to compare adjacent CUSIP pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 81728A207:
Significant Owners of Sensei Biotherapeutics, Inc. - Common Shares, no par value per share (SNSE) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Trails Edge Capital Partners, LP | 9.9% | $1,217,257 | 126,010 | Trails Edge Capital Partners, LP | 18 Feb 2026 |
As of 31 Dec 2025, 10 institutional investors reported holding 48,247 shares of Sensei Biotherapeutics, Inc. - Common Shares, no par value per share (SNSE). This represents 3.8% of the company’s total 1,272,828 outstanding shares.